Literature DB >> 23176819

Germline Mutation in EXPH5 Implicates the Rab27B Effector Protein Slac2-b in Inherited Skin Fragility.

John A McGrath1, Kristina L Stone, Rumena Begum, Michael A Simpson, Patricia J Dopping-Hepenstal, Lu Liu, James R McMillan, Andrew P South, Celine Pourreyron, W H Irwin McLean, Anna E Martinez, Jemima E Mellerio, Maddy Parsons.   

Abstract

The Rab GTPase Rab27B and one of its effector proteins, Slac2-b (also known as EXPH5, exophilin-5), have putative roles in intracellular vesicle trafficking but their relevance to human disease is not known. By using whole-exome sequencing, we identified a homozygous frameshift mutation in EXPH5 in three siblings with inherited skin fragility born to consanguineous Iraqi parents. All three individuals harbor the mutation c.5786delC (p.Pro1929Leufs(∗)8) in EXPH5, which truncates the 1,989 amino acid Slac2-b protein by 52 residues. The clinical features comprised generalized scale-crusts and occasional blisters, mostly induced by trauma, as well as mild diffuse pigmentary mottling on the trunk and proximal limbs. There was no increased bleeding tendency, no neurologic abnormalities, and no increased incidence of infection. Analysis of an affected person's skin showed loss of Slac2-b immunostaining (C-terminal antibody), disruption of keratinocyte adhesion within the lower epidermis, and an increased number of perinuclear vesicles. A role for Slac2-b in keratinocyte biology was supported by findings of cytoskeletal disruption (mainly keratin intermediate filaments) and decreased keratinocyte adhesion in both keratinocytes from an affected subject and after shRNA knockdown of Slac2-b in normal keratinocytes. Slac2-b was also shown to colocalize with Rab27B and β4 integrin to early adhesion initiation sites in spreading normal keratinocytes. Collectively, our findings identify an unexpected role for Slac2-b in inherited skin fragility and expand the clinical spectrum of human disorders of GTPase effector proteins.
Copyright © 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23176819      PMCID: PMC3516608          DOI: 10.1016/j.ajhg.2012.10.012

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

Review 1.  Cellular integrity plus: organelle-related and protein-targeting functions of intermediate filaments.

Authors:  Diana M Toivola; Guo-Zhong Tao; Aida Habtezion; Jian Liao; M Bishr Omary
Journal:  Trends Cell Biol       Date:  2005-10-03       Impact factor: 20.808

Review 2.  Regulation of secretory vesicle traffic by Rab small GTPases.

Authors:  M Fukuda
Journal:  Cell Mol Life Sci       Date:  2008-09       Impact factor: 9.261

Review 3.  Versatile role of Rab27 in membrane trafficking: focus on the Rab27 effector families.

Authors:  Mitsunori Fukuda
Journal:  J Biochem       Date:  2005-01       Impact factor: 3.387

Review 4.  Itinerant exosomes: emerging roles in cell and tissue polarity.

Authors:  Aparna Lakkaraju; Enrique Rodriguez-Boulan
Journal:  Trends Cell Biol       Date:  2008-04-07       Impact factor: 20.808

5.  Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.

Authors:  J Wolfers; A Lozier; G Raposo; A Regnault; C Théry; C Masurier; C Flament; S Pouzieux; F Faure; T Tursz; E Angevin; S Amigorena; L Zitvogel
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

6.  Alzheimer's disease beta-amyloid peptides are released in association with exosomes.

Authors:  Lawrence Rajendran; Masanori Honsho; Tobias R Zahn; Patrick Keller; Kathrin D Geiger; Paul Verkade; Kai Simons
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-12       Impact factor: 11.205

7.  Rab27a and Rab27b control different steps of the exosome secretion pathway.

Authors:  Matias Ostrowski; Nuno B Carmo; Sophie Krumeich; Isabelle Fanget; Graça Raposo; Ariel Savina; Catarina F Moita; Kristine Schauer; Alistair N Hume; Rui P Freitas; Bruno Goud; Philippe Benaroch; Nir Hacohen; Mitsunori Fukuda; Claire Desnos; Miguel C Seabra; François Darchen; Sebastian Amigorena; Luis F Moita; Clotilde Thery
Journal:  Nat Cell Biol       Date:  2009-12-06       Impact factor: 28.824

8.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nucleic Acids Res       Date:  2010-07-03       Impact factor: 16.971

9.  Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes.

Authors:  Claudia Chavez-Muñoz; Ruhangiz T Kilani; Aziz Ghahary
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

10.  Cells release prions in association with exosomes.

Authors:  Benoit Fevrier; Didier Vilette; Fabienne Archer; Damarys Loew; Wolfgang Faigle; Michel Vidal; Hubert Laude; Graça Raposo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

View more
  16 in total

1.  The missense mutation p.R1303Q in type XVII collagen underlies junctional epidermolysis bullosa resembling Kindler syndrome.

Authors:  Cristina Has; Dimitra Kiritsi; Jemima E Mellerio; Claus-Werner Franzke; Emma Wedgeworth; Iliana Tantcheva-Poor; Kristin Kernland-Lang; Peter Itin; Michael A Simpson; Patricia J Dopping-Hepenstal; Wataru Fujimoto; John A McGrath; Leena Bruckner-Tuderman
Journal:  J Invest Dermatol       Date:  2013-09-04       Impact factor: 8.551

2.  Molecular heterogeneity of epidermolysis bullosa simplex: contribution of EXPH5 mutations.

Authors:  Manuela Pigors; Agnes Schwieger-Briel; Juna Leppert; Dimitra Kiritsi; Jürgen Kohlhase; Leena Bruckner-Tuderman; Cristina Has
Journal:  J Invest Dermatol       Date:  2013-09-04       Impact factor: 8.551

3.  Monoallelic Mutations in the Translation Initiation Codon of KLHL24 Cause Skin Fragility.

Authors:  Yinghong He; Kristin Maier; Juna Leppert; Ingrid Hausser; Agnes Schwieger-Briel; Lisa Weibel; Martin Theiler; Dimitra Kiritsi; Hauke Busch; Melanie Boerries; Katariina Hannula-Jouppi; Hannele Heikkilä; Kaisa Tasanen; Daniele Castiglia; Giovanna Zambruno; Cristina Has
Journal:  Am J Hum Genet       Date:  2016-11-23       Impact factor: 11.025

Review 4.  Exome sequencing greatly expedites the progressive research of Mendelian diseases.

Authors:  Xuejun Zhang
Journal:  Front Med       Date:  2014-01-03       Impact factor: 4.592

5.  Exophilin-5 Supports Lysosome-Mediated Trafficking Required for Epidermal Differentiation.

Authors:  Christine L Monteleon; In Young Lee; Todd W Ridky
Journal:  J Invest Dermatol       Date:  2019-05-11       Impact factor: 8.551

6.  Exophilin-5 regulates allergic airway inflammation by controlling IL-33-mediated Th2 responses.

Authors:  Katsuhide Okunishi; Hao Wang; Maho Suzukawa; Ray Ishizaki; Eri Kobayashi; Miho Kihara; Takaya Abe; Jun-Ichi Miyazaki; Masafumi Horie; Akira Saito; Hirohisa Saito; Susumu Nakae; Tetsuro Izumi
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

7.  [The many facets of inherited skin fragility].

Authors:  C Has; D Kiritsi
Journal:  Hautarzt       Date:  2014-06       Impact factor: 0.751

8.  Rat model for dominant dystrophic epidermolysis bullosa: glycine substitution reduces collagen VII stability and shows gene-dosage effect.

Authors:  Alexander Nyström; Jens Buttgereit; Michael Bader; Tatiana Shmidt; Cemil Ozcelik; Ingrid Hausser; Leena Bruckner-Tuderman; Johannes S Kern
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

9.  Discovery in genetic skin disease: the impact of high throughput genetic technologies.

Authors:  Thiviyani Maruthappu; Claire A Scott; David P Kelsell
Journal:  Genes (Basel)       Date:  2014-08-04       Impact factor: 4.096

10.  CALML5 is a ZNF750- and TINCR-induced protein that binds stratifin to regulate epidermal differentiation.

Authors:  Bryan K Sun; Lisa D Boxer; Julia D Ransohoff; Zurab Siprashvili; Kun Qu; Vanessa Lopez-Pajares; S Tyler Hollmig; Paul A Khavari
Journal:  Genes Dev       Date:  2015-11-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.